Update shared on31 Jul 2025
Fair value Increased 15%Sleep Number’s consensus price target has increased, primarily reflecting a meaningful rise in its forward P/E multiple despite stable net profit margins, raising the fair value estimate from $6.50 to $7.50.
What's in the News
- Sleep Number expects full year 2025 net sales of approximately $1.45 billion, reflecting an estimated 14% year-over-year decline.
- Bob Ryder appointed interim CFO; Francis Lee steps down but remains as advisor for the transition period.
- Shareholder attempts to declassify the board and eliminate supermajority voting requirements for directors and certain transactions failed, as required vote thresholds were not met.
- No shares were repurchased between December 29, 2024 and March 29, 2025; the company has completed the repurchase program initiated in 2006.
Valuation Changes
Summary of Valuation Changes for Sleep Number
- The Consensus Analyst Price Target has significantly risen from $6.50 to $7.50.
- The Future P/E for Sleep Number has significantly risen from 8.95x to 10.52x.
- The Net Profit Margin for Sleep Number remained effectively unchanged, moving only marginally from 1.40% to 1.37%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.